{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:36:25Z","timestamp":1791246985889,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T00:00:00Z","timestamp":1589068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jaci.2020.04.033","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:00:55Z","timestamp":1588719655000},"page":"309-320.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Efficacy and safety of anti-CD45\u2013saporin as conditioning agent for RAG deficiency"],"prefix":"10.1016","volume":"147","author":[{"given":"Maria Carmina","family":"Castiello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Bosticardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Sacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Calzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Draghici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Corsino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Bortolomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Sereni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Uva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Palchaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Scadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.04.033_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.04.033_bib2","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease\u00a0(SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12729","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia","volume":"287","author":"Puck","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2020.04.033_bib5","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month post-transplant CD4 count predict survival and immune recovery: a PIDTC Retrospective Study","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib6","first-page":"217","article-title":"Gene therapy for severe combined immunodeficiencies and beyond","author":"Fischer","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.04.033_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2013-01-476432","article-title":"SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID","volume":"123","author":"Schuetz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-01-0061","article-title":"Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients","volume":"108","author":"Liu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib9","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3389\/fimmu.2019.02680","article-title":"Delineating human B cell precursor development with genetically identified PID cases as a model","volume":"10","author":"Wentink","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fped.2019.00434","article-title":"Conditioning perspectives for primary immunodeficiency stem cell transplants","volume":"7","author":"Shaw","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2020.04.033_bib11","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.04.033_bib12","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1172\/JCI91162","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"126","author":"Walter","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.04.033_bib13","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in\u00a0patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.04.033_bib14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jaci.2020.04.033_bib15","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1182\/blood-2010-07-295949","article-title":"Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice","volume":"116","author":"Xue","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib16","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood-2018-06-858159","article-title":"Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice","volume":"133","author":"Pang","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41467-018-08201-x","article-title":"Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation","volume":"10","author":"Czechowicz","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2020.04.033_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41467-018-08202-w","article-title":"Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2020.04.033_bib19","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/bloodadvances.2019000516","article-title":"Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A\u00a0mice","volume":"3","author":"Gao","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2020.04.033_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/bbmt.2003.50024","article-title":"Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy","volume":"9","author":"Krance","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2020.04.033_bib21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(09)60945-4","article-title":"Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1\/2 study","volume":"374","author":"Straathof","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.04.033_bib22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/toxins5101698","article-title":"Saporin-S6: a useful tool in cancer therapy","volume":"5","author":"Polito","year":"2013","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jaci.2020.04.033_bib23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.3584","article-title":"Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin","volume":"34","author":"Palchaudhuri","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2020.04.033_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2017-12-820985","article-title":"Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development","volume":"132","author":"Ott de Bruin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.04.033_bib26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaci.2017.11.015","article-title":"Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation","volume":"142","author":"Capo","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ajhg.2019.07.014","article-title":"Heterozygous FOXN1 variants cause low TRECs and severe T cell lymphopenia, revealing a crucial role of FOXN1 in supporting early thymopoiesis","volume":"105","author":"Bosticardo","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2020.04.033_bib28","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.bbmt.2018.12.101","article-title":"A CD117-amanitin antibody drug conjugate (ADC) effectively depletes human and non-human primate hematopoietic stem and progenitor cells (HSPCs): targeted non-genotoxic conditioning for bone marrow transplant","volume":"25","author":"Pearse","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"S1","key":"10.1016\/j.jaci.2020.04.033_bib29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2019-125968","article-title":"A single dose of CD117 antibody drug conjugate enables autologous gene-modified hematopoietic stem cell transplant (gene therapy) in nonhuman primates","volume":"134","author":"Tisdale","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41577-019-0238-0","article-title":"Thymic epithelial cell heterogeneity: TEC by TEC","volume":"20","author":"Kadouri","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2009-03-211029","article-title":"Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome","volume":"114","author":"Poliani","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib32","first-page":"259","article-title":"Rag defects and thymic stroma: lessons from animal models","volume":"5","author":"Marrella","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","article-title":"Hypomorphic Rag mutations can cause destructive midline granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib34","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.jaci.2017.08.001","article-title":"Abnormalities of T-cell receptor repertoire in CD4(+) regulatory and conventional T cells in patients with RAG mutations: implications for autoimmunity","volume":"140","author":"Rowe","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaci.2019.03.022","article-title":"Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices","volume":"144","author":"Daley","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.033_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/hum.2015.021","article-title":"(211)Astatine-conjugated monoclonal CD45 antibody-based nonmyeloablative conditioning for stem cell gene therapy","volume":"26","author":"Burtner","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jaci.2020.04.033_bib37","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/0008-5472.CAN-08-4363","article-title":"Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the \u03b1-emitting radionuclides bismuth-213 or astatine-211","volume":"69","author":"Nakamae","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2020.04.033_bib38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2011-09-380436","article-title":"Durable donor engraftment after radioimmunotherapy using \u03b1-emitter astatine-211\u2013labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.04.033_bib39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaci.2017.11.015","article-title":"Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation","volume":"142","author":"Capo","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920306291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920306291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:29:25Z","timestamp":1758792565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920306291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0091674920306291"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.04.033","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of anti-CD45\u2013saporin as conditioning agent for RAG deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}